Researchers in the US have launched a clinical trial to test a drug with the potential to slow the progression of Lewy body dementia.

The biotech company Amprion have developed a test to detect the early signs of Parkinson's, before the onset of symptoms, which they hope will be ready to market in the next 18 months.

Our values shape the new volunteer awards, so we take a look at some of the volunteers showcasing them.

People with bipolar disorder are almost 7 times more likely to develop Parkinson's than those without the condition, according to new research published in the journal Neurology.

A brief update on the progress of our mental health campaigning 

Parkinson's UK Northern Ireland launched its early onset Parkinson's cafe, Belfast in June 2017. We catch up on how it's going.

A report on a recent meeting with the new Minister for Disabled People, Health and Work.

Pension  Credit changes and what it could mean for people with Parkinson's and their carers.

The media reports on a large-scale study that suggests the removal of the appendix may increase the risk of Parkinson's.

Axovant Gene Therapies Ltd., a company developing innovative gene therapies, has announced they are entering the next stage of a phase II gene therapy trial for Parkinson's.